Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?

Published:2018-07-26 Issue:3 Volume:68 Page:435-443
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Yaro Seydou¹,Njanpop Lafourcade Berthe-Marie²,Ouangraoua Soumeya¹,Ouoba Aline¹,Kpoda Hervé¹,Findlow Helen³,Tall Haoua²,Seanehia Joy⁴,Martin Catherine²,Ouedraogo Jean-Bosco⁵,Gessner Bradford²,Meda Nicolas¹,Borrow Ray³,Trotter Caroline⁶,Mueller Judith E⁴

Affiliation:

1. Centre MURAZ, Bobo-Dioulasso, Burkina Faso

2. Agence de Medecine Preventive, Paris, France

3. Vaccine Evaluation Unit, Public Health England, Manchester, United Kingdom

4. EHESP French School of Public Health, Sorbonne Paris Cité, France et Institut Pasteur, Paris

5. Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso

6. Cambridge University, United Kingdom

Funder

Meningitis Research Foundation, Bristol, United Kingdom

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/3/435/27512588/ciy488.pdf

Reference21 articles.

1. La méningite cérébrospinale en Afrique;Lapeyssonie;Bull World Health Organ,1963

2. Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overview;Agier;Int J Infect Dis,2017

3. Successful African introduction of a new Group A meningococcal conjugate vaccine: future challenges and next steps;LaForce;Hum Vaccin Immunother,2018

4. Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign;Diallo;PLoS One,2017

5. Antibody persistence 1-5 years following vaccination with MenAfriVac in African children vaccinated at 12-23 months of age;Tapia;Clin Infect Dis,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling study;eClinicalMedicine;2023-02

2. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines;Plotkin's Vaccines;2023

3. Meningococcal Vaccines of New Generations – the First 20 Years of Use;Epidemiology and Vaccinal Prevention;2021-09-04

4. Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns;PLOS ONE;2021-07-14

5. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world;eLife;2021-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3